full-text ►
National Guideline Clearinghouse | Aflibercept for treating visual impairment caused by macular oedema secondary to central retinal vein occlusion.
National Institute for Health and Care Excellence (NICE)
Workforce and Patient Safety. April 24, 2024
Hace 4 horas
No hay comentarios:
Publicar un comentario